Patent details

Basic Information

Publication number:

EP3177649

PCT Application Number:

US2015043723

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158297911

PCT Publication Number:

WO2016022630

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-PD-L1 ANTIBODIES

French Title of Invention:

ANTICORPS ANTI-PD-L1

German Title of Invention:

ANTI-PD-L1-ANTIKÖRPER

SPC Number:

Dates

Filing date:

05/08/2015

Grant date:

28/02/2024

EP Publication Date:

14/06/2017

PCT Publication Date:

11/02/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/02/2024

EP B1 Publication Date:

28/02/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/08/2024

Expiration date:

05/08/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/02/2024

 

 

Name:

Apollomics Inc.

Address:

989 E Hillsdale Blvd, Suite 220, Foster City, CA 94404, United States (US)

Inventor

1

Name:

ZHA, Jiping

Address:

China (CN)

2

Name:

QIU, Junzhuan

Address:

China (CN)

3

Name:

SUN, Ziyong

Address:

China (CN)

Priority

Priority Number:

PCT/CN2014/083715

Priority Date:

05/08/2014

Priority Country:

World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:

A61P 31/04; A61P 31/10; A61P 31/12; A61P 31/16; A61P 33/00; A61P 31/06; A61P 35/00; A61P 35/02; C07K 16/28; A61P 33/06; A61P 33/12; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

202409

Publication date:

28/02/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages